Daily non-political popular news in brief.

Statin use linked with decreased prostate cancer mortality rates, lower PSA levels

In recent years, research has indicated a possible link between dietary fat intake and prostate cancer. Research presented today at the 102nd Annual Scientific Meeting of the American Urological Association explores the effect statin medications (which work to reduce low-density lipoprotein, or LDL, levels) may have on prostate-specific antigen, the incidence of prostate cancer, and mortality due to prostate cancer.

Read more »

Keywords: statin, linked, decreased, prostate, cancer, mortality, rates, lower, psa, levels, rate, level

« Previous | Next »

Similar news on "Statin use linked with decreased prostate cancer mortality rates, lower PSA levels":

1. Statin use linked with decreased prostate cancer mortality rates; lower PSA levels
   05-20-2007 · EurekAlert!
   In recent years, research has indicated a possible link between dietary fat intake and prostate cancer. Research presented today at the 102nd Annual Scientific Meeting of the American Urological Association explores the effect statin medications (which work to reduce low-density lipoprotein, or LDL, levels) may have on prostate-specific antigen, the incidence of prostate cancer, and mortality due to prostate cancer.
   Similar news · Read more »
   
2. High PSA velocity linked with low survival rates
   10-31-2006 · EurekAlert!
   The rate at which prostate-specific antigen levels change may help identify men with life-threatening prostate cancer, according to a study in the November 1 issue of the Journal of the National Cancer Institute.
   Similar news · Read more »
   
3. PSA doubling predicts prostate cancer recurrence
   04-09-2007 · EurekAlert!
   A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. Doubling time is defined as the duration for PSA levels in the blood to increase by 100 percent.
   Similar news · Read more »
   
4. PSA velocity's clinical usefulness remains unclear
   10-09-2007 · EurekAlert!
   Some studies have suggested that the rate of change of prostate-specific antigen levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool, according to a commentary published online Oct. 9 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
5. High pretreatment PSA velocity predicts worse outcome
   05-25-2007 · EurekAlert!
   The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study.
   Similar news · Read more »
   
6. Long-term use of adult-strength aspirin linked to a moderate decreased cancer risk
   04-17-2007 · EurekAlert!
   A daily dose of adult-strength aspirin may modestly reduce cancer risk in populations with high rates of colorectal, prostate, and breast cancer if taken for at least five years.
   Similar news · Read more »
   
7. Obesity-linked high blood volumes render PSA prostate cancer test less effective, study suggests
   11-20-2007 · EurekAlert!
   The extra blood volume produced in the obese may so dilute levels of a telltale protein produced by prostates that the popular PSA test may be essentially useless for diagnosing prostate cancer in men carrying extra pounds, a new study in the Journal of the American Medical Association suggests.
   Similar news · Read more »
   
8. Obesity associated with lower PSA levels in men with prostate cancer
   11-20-2007 · EurekAlert!
   Higher body mass index is associated with higher plasma volume, which may be related to lower prostate-specific antigen levels among obese men, according to a study in the Nov. 21 issue of JAMA.
   Similar news · Read more »
   
9. Prostate cancer patients see high survival rates with seed implants
   01-31-2007 · EurekAlert!
   More than 90 percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis, according to a study released in the February 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of ASTRO.
   Similar news · Read more »
   
10. Insurance status linked to cancer outcomes
    12-20-2007 · EurekAlert!
    A new report from the American Cancer Society finds substantial evidence that lack of adequate health insurance coverage is associated with less access to care and poorer outcomes for cancer patients. The report finds the uninsured are less likely to receive recommended cancer screening tests, are more likely to be diagnosed with later stage disease, and have lower survival rates than those with private insurance for several cancers.
    Similar news · Read more »